Biovie Financial Statements From 2010 to 2026

BIVI Stock  USD 1.24  0.10  8.77%   
Biovie's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biovie's valuation are provided below:
Market Capitalization
11.2 M
Earnings Share
(12.12)
We have found one hundred twenty available fundamental signals for Biovie Inc, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Biovie Inc prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 185.1 K, Other Operating Expenses of 22.9 M or Total Operating Expenses of 22.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0132 or PTB Ratio of 0.79. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
Build AI portfolio with Biovie Stock
Check out the analysis of Biovie Correlation against competitors.

Biovie Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26 M24.8 M10.2 M
Slightly volatile
Total Current Liabilities4.9 M2.6 M3.9 M
Slightly volatile
Accounts Payable2.7 M2.5 MM
Slightly volatile
Cash21.2 M20.2 M7.5 M
Slightly volatile
Cash And Short Term Investments21.2 M20.2 M8.4 M
Slightly volatile
Common Stock Total Equity2.1 K2.2 K8.2 K
Pretty Stable
Common Stock Shares Outstanding1.8 M1.7 M424 K
Slightly volatile
Liabilities And Stockholders Equity26 M24.8 M10.2 M
Slightly volatile
Other Stockholder Equity448.2 M426.8 M143.5 M
Slightly volatile
Total Liabilities2.8 M2.9 M4.9 M
Slightly volatile
Total Current Assets25 M23.8 M9.1 M
Slightly volatile
Common Stock7.8 K6.7 K9.4 K
Pretty Stable
Short and Long Term Debt Total382.3 K402.4 K2.9 M
Slightly volatile
Capital Stock8.4 K6.7 K29.1 K
Slightly volatile

Biovie Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization185.1 K263.8 K163.3 K
Slightly volatile
Other Operating Expenses22.9 M20.8 M18.5 M
Slightly volatile
Total Operating Expenses22.9 M20.5 M18.5 M
Slightly volatile
Interest Expense363.5 K382.6 K943.2 K
Slightly volatile
Selling General Administrative10.3 M9.9 M4.1 M
Slightly volatile
Research Development20.1 M10.7 M14.7 M
Slightly volatile
Interest IncomeM981 K272.4 K
Slightly volatile
Reconciled Depreciation183.5 K206.4 K225.3 K
Slightly volatile

Biovie Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow21.2 M20.2 M7.8 M
Slightly volatile
Stock Based Compensation2.2 M2.8 M1.7 M
Slightly volatile
Begin Period Cash Flow28.8 M27.4 M7.4 M
Slightly volatile
Depreciation203.3 K263.8 K166.9 K
Slightly volatile
Change To Netincome16.2 M11.4 M11.4 M
Slightly volatile
Issuance Of Capital Stock23.8 M18 M12.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.01320.01480.0162
Slightly volatile
Average Payables324.4 K597.5 K457.6 K
Slightly volatile
Capex To Depreciation0.00.00.0
Slightly volatile
Payables Turnover0.080.09380.1022
Slightly volatile
Cash Per Share10.1510.6925.4533
Slightly volatile
Days Payables Outstanding2.8 K3.2 K3.4 K
Slightly volatile
Income Quality1.020.980.5316
Slightly volatile
Intangibles To Total Assets0.02660.02790.5684
Slightly volatile
Current Ratio10.9910.468.8455
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Interest Debt Per Share0.50.5322.7394
Pretty Stable
Debt To Assets0.01390.01460.1887
Slightly volatile
Days Of Payables Outstanding2.8 K3.2 K3.4 K
Slightly volatile
Ebt Per Ebit1.110.871.2945
Very volatile
Effective Tax Rate3.0E-43.0E-46.0E-4
Slightly volatile
Quick Ratio10.9910.468.8455
Slightly volatile
Cash Ratio4.928.878.1993
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9824
Slightly volatile
Debt Ratio0.01390.01460.1887
Slightly volatile

Biovie Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap20.6 M21.6 M37.6 M
Slightly volatile
Enterprise Value1.2 M1.3 M22.6 M
Slightly volatile

Biovie Fundamental Market Drivers

Biovie Upcoming Events

9th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Biovie Financial Statements

Investors use fundamental indicators, such as Biovie's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biovie's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.2 M-3.1 M
Cost Of Revenue263.8 K198.1 K

Currently Active Assets on Macroaxis

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is there potential for Biotechnology market expansion? Will Biovie introduce new products? Factors like these will boost the valuation of Biovie. Projected growth potential of Biovie fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.12)
Return On Assets
(0.50)
Return On Equity
(0.95)
Understanding Biovie Inc requires distinguishing between market price and book value, where the latter reflects Biovie's accounting equity. The concept of intrinsic value—what Biovie's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Biovie's price substantially above or below its fundamental value.
It's important to distinguish between Biovie's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biovie should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biovie's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.